Status:

COMPLETED

The PROAKTIV Study

Lead Sponsor:

Insel Gruppe AG, University Hospital Bern

Collaborating Sponsors:

Swiss National Science Foundation

University of Bern

Conditions:

Palliative Care

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The overall objective of this study is to identify whether the systematic anticipation of highly structured specialized palliative home care into primary care influences the quality of care and care u...

Detailed Description

The University Center for Palliative Care from the Inselspital Bern conducts this monocentric mixed-methods controlled study and is responsible for informed consent. Data consists of questionnaires o...

Eligibility Criteria

Inclusion

  • Patients inclusion criteria:
  • 18 years or older
  • Able to read and understand German
  • Able to fill out questionnaires with only minimal assistance
  • Live in the catchment area of SPHC
  • Positive screening on the palliative care screening tools
  • Expected survival time of approximately six months or less
  • Have a GP (or GP medical substitute)
  • Registered with Spitex care
  • Wish to live at home as long as possible (no plans for long term nursing home uptake)
  • Written informed consent
  • Patients exclusion criteria:
  • Planned discharged from hospitals to institutions (e.g. other hospitals, rehabilitations, nursing homes)
  • Live permanently in nursing homes
  • Cognitive impairments that make it impossible to follow the study (e.g. psychological disorders, dementia, loss of judgement).
  • Family caregivers inclusion criteria:
  • 18 years or older
  • Able to read and understand German
  • Familiar with the care situation patient
  • Written informed consent
  • Specialized palliative home care team:
  • Provide care in German speaking part of canton Bern
  • 24/7-availability of specialized palliative care
  • Specialized palliative care team including nurses and consulting physician with specialized palliative care certification.

Exclusion

    Key Trial Info

    Start Date :

    September 7 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2023

    Estimated Enrollment :

    149 Patients enrolled

    Trial Details

    Trial ID

    NCT04673760

    Start Date

    September 7 2020

    End Date

    August 1 2023

    Last Update

    November 29 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital Inselspital Bern

    Bern, Switzerland